Stockscreener 앱 받기
1.00
11.96%
0.1068
시간 외 거래:
1.02
0.02
+2.00%
전일 마감가:
$0.8932
열려 있는:
$0.9394
하루 거래량:
96,392
Relative Volume:
0.58
시가총액:
$62.61M
수익:
$33.79M
순이익/손실:
$-18.67M
주가수익비율:
-2.7917
EPS:
-0.3582
순현금흐름:
$-19.17M
1주 성능:
+15.05%
1개월 성능:
-4.76%
6개월 성능:
-1.96%
1년 성능:
-3.85%
1일 변동 폭
$0.9095
$1.0066
1주일 범위
$0.8413
$1.0066
52주 변동 폭
$0.7101
$1.61
Cytosorbents Corp Stock (CTSO) Company Profile
명칭
Cytosorbents Corp
전화
973-329-8885
주소
305 COLLEGE ROAD EAST, PRINCETON, NJ
CTSO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
1.00 | 56.47M | 33.79M | -18.67M | -19.17M | -0.3582 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-07 | 개시 | B. Riley Securities | Buy |
| 2021-10-14 | 재개 | B. Riley Securities | Buy |
| 2020-09-17 | 개시 | Jefferies | Buy |
| 2020-09-01 | 개시 | SVB Leerink | Outperform |
| 2017-08-08 | 재확인 | Maxim Group | Buy |
| 2016-10-26 | 개시 | Aegis Capital | Buy |
| 2016-05-24 | 개시 | Maxim Group | Buy |
| 2015-10-29 | 업그레이드 | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | 재확인 | MLV & Co | Buy |
| 2015-04-01 | 재확인 | MLV & Co | Buy |
| 2015-03-05 | 개시 | MLV & Co | Buy |
| 2015-02-25 | 개시 | WBB Securities | Speculative Buy |
| 2015-01-27 | 재확인 | H.C. Wainwright | Buy |
모두보기
Cytosorbents Corp 주식(CTSO)의 최신 뉴스
Reversal indicators forming on Cytosorbents Corporation stockTechnical Safety Zone Pattern Recognition - Newser
Is this a good reentry point in Cytosorbents CorporationFree Entry and Exit Strategy Optimizer Tool - Newser
How sentiment analysis helps forecast Cytosorbents CorporationFree Fast Gaining Stock Screener Report - Newser
How to forecast Cytosorbents Corporation trends using time seriesHigh Return Strategy with Low Risk - Newser
How Cytosorbents Corporation stock performs during market volatilityTechnical Screener for High Growth Stocks - Newser
Earnings call transcript: CytoSorbents Q2 2025 revenue miss, stock dips By Investing.com - Investing.com Canada
Earnings call transcript: CytoSorbents Q2 2025 revenue miss, stock dips - Investing.com
CytoSorbents Corp (CTSO) Q2 2025 Earnings Call Highlights: Strat - GuruFocus
CytoSorbents Reports Positive Q2 2025 Financial Results - TipRanks
Cytosorbents Corp reports results for the quarter ended June 30Earnings Summary - TradingView
CytoSorbents: Q2 Earnings Snapshot - San Antonio Express-News
CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire
What institutions are buying Cytosorbents Corporation stock nowValue Investing Summary and Earnings Outlook - Newser
Will Cytosorbents Corporation continue its uptrendIntraday Signal Forecast for Fast Traders - Newser
What MACD signals say about Cytosorbents CorporationWeekly Market Direction and Sector Summary - Newser
Can volume confirm reversal in Cytosorbents CorporationHigh Reward Investment Strategy for Beginners - Newser
Why Cytosorbents Corporation stock attracts strong analyst attentionFree Pattern Detection for Entry Confirmation - Newser
Cytosorbents Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
How to recover losses in Cytosorbents Corporation stockAI Pattern Recognition and Trade Prediction - Newser
Tools to assess Cytosorbents Corporation’s risk profileFree Real Time Alerts Based on AI Prediction - Newser
Is Cytosorbents Corporation stock overvalued or undervaluedAchieve rapid portfolio growth with expert guidance - Jammu Links News
Is it the right time to buy Cytosorbents Corporation stockBuild a portfolio that delivers consistent profits - Jammu Links News
Breakthrough Sepsis Treatment: CytoSorb Therapy Achieves 70% Survival Rate in Latest Clinical Studies - Stock Titan
CytoSorbents Leads a New Era in Sepsis Treatment - Nasdaq
What makes Cytosorbents Corporation stock price move sharplyWeekly High Conviction Trade Setup Analysis - Newser
Should you wait for a breakout in Cytosorbents CorporationFree Wealth Building Stock Market Ideas - Newser
Medical Tech Leader CytoSorbents Sets Q2 2025 Earnings Call: Key Updates Expected on ICU Treatment Solutions - Stock Titan
Why is Cytosorbents Corporation stock attracting strong analyst attentionHigh-profit stock alerts - Jammu Links News
Is Cytosorbents Corporation a growth stock or a value stockAchieve consistent double-digit returns - Jammu Links News
What are the latest earnings results for Cytosorbents CorporationUnlock powerful insights from market experts - Jammu Links News
Is Cytosorbents Corporation stock a good hedge against inflationAccelerated financial growth - jammulinksnews.com
What analysts say about Cytosorbents Corporation stockUnmatched market performance - jammulinksnews.com
What drives Cytosorbents Corporation stock priceStrongest growth potential - Jammu Links News
Cytosorbents (NASDAQ:CTSO) Given “Buy” Rating at D. Boral Capital - Defense World
CytoSorbents (CTSO) Stock Rating and Price Target Maintained by - GuruFocus
Is Cytosorbents Corporation a good long term investmentExtraordinary profit generation - jammulinksnews.com
Cytosorbents Corp (CTSO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):